Table 1 Demographic details of the patients with asthma across different COVID-19 severity groups
From: Pre-existing asthma as a comorbidity does not modify cytokine responses and severity of COVID-19
|  | Asthma with critical COVID-19 (n = 3) | Asthma with severe COVID-19 (n = 10) | Asthma with mild COVID-19 (n = 3) |
|---|---|---|---|
Age | 70 ± 11 | 56 ± 16 | 37 ± 17 |
BMI (kg/cm2) | 27.52 ± 6.74 | 28.92 ± 4.63 | 26.94 ± 1.74 |
Gender (M/F) | 3/0 | 7/3 | 1/2 |
Asthma severity (mild/severe) | 3/0 | 10/0 | 3/0 |
Eosinophilic asthma | 0 | 2 | 1 |
Blood eosinophil counts (cells/μL) | 150 ± 36 | 210 ± 108 | 220 ± 0 |
PEF (L/min) | 520 ± 0 | 500 ± 151 | 150 ± 0 |
FEV1 (L/min) | NA | 2.78 ± 1.28 | NA |
FEV1/FVC (%) | NA | 85.00 ± 4.24 | NA |
FeNO (ppb) | NA | NA | NA |
ICS | Yes | Yes | Yes |
OCS | No | No | No |
Biological treatments | No | No | No |